ArticleClinical rheumatology2026

Tofacitinib versus BAFF inhibitor in mild to moderate systemic lupus erythematosus: a real-world study based on CSTAR cohort.

Yutong Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.